WNK2 and breast cancer: At the same time, they were found to improve radiotherapy efficiency by enhancing apoptosis, blocking the cell cycle, and reducing the proliferation of breast cancer cells by downregulating iron levels and mitogen-activated protein kinases (MAPK/P38).